BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin's disease
John Durant(University of Alabama at Birmingham), Ronald F. Dorfman(Stanford Medicine), David D. Wirtschafter(University of Alabama), Richard A. Gams(Breast Center), E Vélez-García(Breast Center), Alfred A. Bartolucci(University of Alabama at Birmingham)
Cited by 38
Related Papers
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
|Journal of Clinical Oncology|1997|652
A common progenitor for human myeloid and lymphoid cells
|Nature|1978|277
Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.
|Journal of Clinical Oncology|1997|269
An Instrument to Measure Healing in Pressure Ulcers: Development and Validation of the Pressure Ulcer Scale for Healing (PUSH)
|The Journals of Gerontology Series A|2001|205
Lymphoblastic lymphoma: A clinicopathologic study of 95 patients
|Cancer|1981|175